Insider Trading & Ownership of Pivotal bioVenture Partners Fund I, L.P.

Location
San Francisco, CA
Summary
The estimated value of insider holdings of Pivotal bioVenture Partners Fund I, L.P. is at least $5,611,115 dollars as of 12 Nov 2025. Pivotal bioVenture Partners Fund I, L.P. is the Director of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. stock worth about $5.61M.
Signature
/s/ Robert Hopfner - for Pivotal bioVenture Partners Fund I, L.P., By: Robert Hopfner, Managing Partner
All Insider Reports
All Insider Reports

Notify me when Pivotal bioVenture Partners Fund I, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Pivotal bioVenture Partners Fund I, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INZY Inozyme Pharma, Inc. Director $5,611,115 01 Aug 2023
EVMN Evommune, Inc. Director, 10%+ Owner 07 Nov 2025

Insider Transactions Reported by Pivotal bioVenture Partners Fund I, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.